Book description
-
70-chapter authoritative reference that covers therapeutic
monoclonal antibody discovery, development, and clinical
applications while incorporating principles, experimental data,
and methodologies.
-
First book to address the discovery and development of antibody
therapeutics in their entirety.
-
Most chapters contain experimental data to illustrate the
principles described in them.
-
Authors provide detailed methodologies that readers can take
away with them and use in their own laboratories
Zhiqiang An, PhD
, is the Chief Scientific Officer of Epitomics, Inc., in Burlingame,
California. Previously, he was Director of Biologics Research at Merck
Research Laboratories, West Point, Pennsylvania. Dr. An started his
biotech/pharmaceutical career at Millennium Pharmaceuticals, Inc.,
Cambridge, Massachusetts. He received a doctor of philosophy degree from
the University of Kentucky, Lexington, followed by postdoctoral training
at the University of Wisconsin-Madison.
